Multivariate analysis of the relationship between clinical-biological characteristics and progression in patients with prostate cancer stage C
Vincenzo Mirone(University of Naples Federico II), Francesco Perrone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Ciro Imbimbo(University of Naples Federico II), Fabrizio Iacono(Federico II University Hospital), Sabino De Placido, A. Russo(University of Catania), Alessandro Palmieri(University of Naples Federico II), Domenico Prezioso(Federico II University Hospital)
Acta urologica italica
January 1, 1989
Cited by 0
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
|Breast Cancer Research|2011|224
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
|Cancer Research|2018|221